1620 Investment Advisors, Inc. Tg Therapeutics, Inc. Transaction History
1620 Investment Advisors, Inc.
- $126 Million
- Q4 2024
A detailed history of 1620 Investment Advisors, Inc. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, 1620 Investment Advisors, Inc. holds 4,257 shares of TGTX stock, worth $131,541. This represents 0.1% of its overall portfolio holdings.
Number of Shares
4,257Holding current value
$131,541% of portfolio
0.1%Shares
1 transactions
Others Institutions Holding TGTX
# of Institutions
365Shares Held
90.6MCall Options Held
2.35MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA15.6MShares$482 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$352 Million0.0% of portfolio
-
State Street Corp Boston, MA9.09MShares$281 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.19MShares$98.7 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V82.79MShares$86.3 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.49B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...